Concepedia
Statistics
Publications
4
Citations
143
H-Index
Active since
2009
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (United Kingdom)
University of Gothenburg
AstraZeneca (Finland)
AstraZeneca (Poland)
Janeli Sarv is an author at AstraZeneca (Sweden) specializing in medicine, genetics, and life sciences.
Publications per year
2009–2025
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials
Javier Armisen, Mitra Rauschecker, Janeli Sarv et al. · Journal of Hepatology · 2025 · 53 citations
Life Sciences, Genetics, Molecular Genetics +4
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis
Sudha S. Shankar, Samuel J. Daniels, Darren Robertson et al. · Clinical Gastroenterology and Hepatology · 2024 · 44 citations · Full text
Medicine, Endocrinology, Pharmacology +16
Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD
Alexandra R. Morgan, Geoff J.M. Parker, Caleb Roberts et al. · European Journal of Radiology · 2014 · 33 citations
Medicine, Pharmacology, Pharmacotherapy +15
Predicting functional upstream open reading frames in Saccharomyces cerevisiae
Selpi Selpi, Christopher H. Bryant, Graham JL Kemp et al. · BMC Bioinformatics · 2009 · 13 citations · Full text
Life Sciences, Genetics, Molecular Biology +15
1–4 of 4